IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-675A outperforms existing treatment for arthritis, page-124

  1. 1,205 Posts.
    lightbulb Created with Sketch. 258
    The reality is none of us have any idea of who specifically EAS are targeting & currently speaking to or what level of support being asked/offered.
    I would expect months personally.
    Using the ducks lining up train of thought. Ann's for 6 x trials & still one to come on psychedelics. Maybe looking for financial backing to take these trials through to the next stage? Also support for the US listing with the $ for that to happen.
    Its been said plenty of times before but we have a very astute board that know the process well.
    Peter Widdows alone is an exceptionally talented player in this field.
    Personally I feel very confident of where we are & where we're heading.
    I think quite a few of us see the pieces to the IHL picture just a matter of time on the catalyst Ann's?

    Last edited by ime003: 21/03/21
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.